Uridine Composition of the Poly-U/UC Tract of HCV RNA Defines Non-Self Recognition by RIG-I

PLoS Pathogens

Volumn 8, Issue 8, 2012, Pages

  Schnell, Gretja ^a   Loo, Yueh Ming ^a   Marcotrigiano, Joseph ^b   Gale, Michael ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELICASE; POLYCYTIDYLIC ACID; POLYCYTIDYLIC POLYURIDYLIC ACID; POLYURIDYLIC ACID; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; URIDINE; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INNATE IMMUNITY; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA STRUCTURE; RNA VIRUS INFECTION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

ANIMALS; CELL LINE; DEAD-BOX RNA HELICASES; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNITY, INNATE; LIVER; MICE; POLY U; RNA, VIRAL; SIGNAL TRANSDUCTION;

HEPATITIS C VIRUS; MAMMALIA;

EID: 84866148178     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002839     Document Type: Article

References (53)

1. Loo YM, Gale M Jr, (2011) Immune signaling by RIG-I-like receptors. Immunity 34: 680-692.
2. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, et al.(2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6: 981-988.
3. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, et al.(2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
4. Seth RB, Sun L, Ea CK, Chen ZJ, (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682.
5. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, et al.(2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19: 727-740.
6. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, et al.(2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5: 730-737.
7. Gale M Jr, (2003) Effector genes of interferon action against hepatitis C virus. Hepatology 37: 975-978.
8. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, et al.(2005) Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175: 2851-2858.
9. Saito T, Hirai R, Loo YM, Owen D, Johnson CL, et al.(2007) Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A 104: 582-587.
10. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, et al.(2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314: 994-997.
11. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, et al.(2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314: 997-1001.
12. Schlee M, Roth A, Hornung V, Hagmann CA, Wimmenauer V, et al.(2009) Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31: 25-34.
13. Takahasi K, Yoneyama M, Nishihori T, Hirai R, Kumeta H, et al.(2008) Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 29: 428-440.
14. Wang Y, Ludwig J, Schuberth C, Goldeck M, Schlee M, et al.(2010) Structural and functional insights into 5′-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat Struct Mol Biol 17: 781-787.
15. Jiang F, Ramanathan A, Miller MT, Tang GQ, Gale M, et al.(2011) Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 479: 423-427.
16. Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, et al.(2011) Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA. Cell 147: 423-435.
17. Luo D, Ding SC, Vela A, Kohlway A, Lindenbach BD, et al.(2011) Structural Insights into RNA Recognition by RIG-I. Cell 147: 409-422.
18. Cui S, Eisenacher K, Kirchhofer A, Brzozka K, Lammens A, et al.(2008) The C-terminal regulatory domain is the RNA 5′-triphosphate sensor of RIG-I. Mol Cell 29: 169-179.
19. Lu C, Xu H, Ranjith-Kumar CT, Brooks MT, Hou TY, et al.(2010) The structural basis of 5′ triphosphate double-stranded RNA recognition by RIG-I C-terminal domain. Structure 18: 1032-1043.
20. Lu C, Ranjith-Kumar CT, Hao L, Kao CC, Li P, (2011) Crystal structure of RIG-I C-terminal domain bound to blunt-ended double-strand RNA without 5′ triphosphate. Nucleic Acids Res 39: 1565-1575.
21. Fischer M, Ehlers M, (2008) Toll-like receptors in autoimmunity. Ann N Y Acad Sci 1143: 21-34.
22. Kawasaki T, Kawai T, Akira S, (2011) Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity. Immunol Rev 243: 61-73.
23. Krieg AM, Vollmer J, (2007) Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev 220: 251-269.
24. Marques JT, Devosse T, Wang D, Zamanian-Daryoush M, Serbinowski P, et al.(2006) A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells. Nat Biotechnol 24: 559-565.
25. Schmidt A, Schwerd T, Hamm W, Hellmuth JC, Cui S, et al.(2009) 5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad Sci U S A 106: 12067-12072.
26. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M Jr, (2008) Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454: 523-527.
27. Uzri D, Gehrke L, (2009) Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities. J Virol 83: 4174-4184.
28. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, et al.(2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
29. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, et al.(2008) Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82: 335-345.
30. Alter MJ, (2007) Epidemiology of hepatitis C virus infection. World J Gastroenterol 13: 2436-2441.
31. Shepard CW, Finelli L, Alter MJ, (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558-567.
32. Wasley A, Alter MJ, (2000) Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20: 1-16.
33. Sumpter R Jr, Loo YM, Foy E, Li K, Yoneyama M, et al.(2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79: 2689-2699.
34. Friebe P, Bartenschlager R, (2002) Genetic analysis of sequences in the 3′ nontranslated region of hepatitis C virus that are important for RNA replication. J Virol 76: 5326-5338.
35. Yi M, Lemon SM, (2003) 3′ nontranslated RNA signals required for replication of hepatitis C virus RNA. J Virol 77: 3557-3568.
36. You S, Rice CM, (2008) 3′ RNA elements in hepatitis C virus replication: kissing partners and long poly(U). J Virol 82: 184-195.
37. Blight KJ, Rice CM, (1997) Secondary structure determination of the conserved 98-base sequence at the 3′ terminus of hepatitis C virus genome RNA. J Virol 71: 7345-7352.
38. Milligan JF, Groebe DR, Witherell GW, Uhlenbeck OC, (1987) Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res 15: 8783-8798.
39. Blight KJ, McKeating JA, Rice CM, (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76: 13001-13014.
40. Myong S, Cui S, Cornish PV, Kirchhofer A, Gack MU, et al.(2009) Cytosolic viral sensor RIG-I is a 5′-triphosphate-dependent translocase on double-stranded RNA. Science 323: 1070-1074.
41. Gack MU, Shin YC, Joo CH, Urano T, Liang C, et al.(2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446: 916-920.
42. Horner SM, Liu HM, Park HS, Briley J, Gale M Jr, (2011) Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci U S A 108: 14590-14595.
43. Kageyama M, Takahasi K, Narita R, Hirai R, Yoneyama M, et al.(2011) 55 Amino acid linker between helicase and carboxyl terminal domains of RIG-I functions as a critical repression domain and determines inter-domain conformation. Biochem Biophys Res Commun 415: 75-81.
44. Friebe P, Boudet J, Simorre JP, Bartenschlager R, (2005) Kissing-loop interaction in the 3′ end of the hepatitis C virus genome essential for RNA replication. J Virol 79: 380-392.
45. Loo YM, Owen DM, Li K, Erickson AK, Johnson CL, et al.(2006) Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A 103: 6001-6006.
46. Pawlotsky JM, (2003) Hepatitis C virus genetic variability: pathogenic and clinical implications. Clin Liver Dis 7: 45-66.
47. Pawlotsky JM, (2000) Hepatitis C virus resistance to antiviral therapy. Hepatology 32: 889-896.
48. Pawlotsky JM, Germanidis G, Neumann AU, Pellerin M, Frainais PO, et al.(1998) Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J Virol 72: 2795-2805.
49. Gale M Jr, Foy EM, (2005) Evasion of intracellular host defence by hepatitis C virus. Nature 436: 939-945.
50. Horner SM, Gale M Jr, (2009) Intracellular innate immune cascades and interferon defenses that control hepatitis C virus. J Interferon Cytokine Res 29: 489-498.
51. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, et al.(2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102: 9294-9299.
52. Foy E, Li K, Wang C, Sumpter R Jr, Ikeda M, et al.(2003) Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 300: 1145-1148.
53. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al.(2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791-796.